TAX
Cambria Tax Aware ETF
Cambria Tax Aware ETF aims to provide long-term capital appreciation while minimizing tax impacts through investment in a diversified portfolio of equities and other investments.
US
EQUITY
Active
MANAGEMENT STYLE
$ 23.9 M
ASSETS UNDER MGMT
54 bp
EXPENSES
Fund Basics
| Inception date | Dec 17, 2024 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| CASH & OTHER | 2.3 % |
| ADVANCED MICRO DEVICES | 1.9 % |
| REVOLUTION MEDICINES, INC. | 1.8 % |
| NATERA INC | 1.7 % |
| CHARLES RIVER LABORATORIES | 1.6 % |
| JFROG LTD. | 1.6 % |
| ROIVANT SCIENCES LTD. | 1.6 % |
| TWILIO, INC. CLASS A | 1.6 % |
| VIASAT INC | 1.6 % |
| EXELIXIS INC | 1.5 % |
Constituent Breakdown
| Number of holdings | 97 |
| Herfindahl-Hirschman Index | 111 |
| Wgt avg mkt cap (mns) | $119,368 |
| Large cap (>$10bn) | 66.9% |
| Mid cap ($2-10bn) | 28.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 95.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 90.9 % |
 |
BRITAIN | 1.6 % |
 |
SINGAPORE | 1.2 % |
 |
IRELAND | 1.2 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 6.4% | 9.2% | -- | -- | -- | -- | -- | 12.8% |
| Dividend Yield | 0.0% | 0.4% | -- | -- | -- | -- | -- | 0.4% |
| Total Returns | 6.4% | 9.5% | -- | -- | -- | -- | -- | 13.1% | Ann. Volatility | 16.7% | 16.7% | -- | -- | -- | -- | -- | 18.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.12 | 75% |
| MSCI EAFE | 0.81 | 59% |
| MSCI Emg Mkts | 0.47 | 50% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.20% |
Technical Indicators
| 30d moving avg. (EMA) | $30.61 |
| Relative strength (RSI) | 50 |
| MACD/Signal | 0.01/-0.04 |
| Bollinger Bands (Upper/Lower) | $31.01/$30.05 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. TAX |
Expenses vs. TAX |
ALTAR Score™ vs. TAX |
|---|---|---|---|---|
| LSAF | LeaderShares AlphaFactor US Core Equity ETF | 17.2% | +21 bp | +1.8% |
| LST | Leuthold Select Industries ETF | 16.2% | +31 bp | +1.3% |
| PDP | Invesco Dorsey Wright Momentum ETF | 16.1% | +8 bp | -1.5% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 15.8% | -39 bp | -1.3% |
| BUL | Pacer US Cash Cows Growth ETF | 14.5% | +6 bp | +0.6% |
| BAGX | EA Bridgeway Aggressive Investors ETF | 14.2% | +32 bp | -0.1% |
| USMF | WisdomTree U.S. Multifactor Fund | 14.0% | -26 bp | +1.0% |
| FXH | First Trust Health Care AlphaDEX Fund | 13.8% | +7 bp | -0.4% |
| QGRO | American Century U.S. Quality Growth ETF | 13.6% | -25 bp | -0.1% |
| RPG | Invesco S&P 500 Pure Growth ETF | 13.2% | -19 bp | -2.3% |
Risk and Returns: TAX vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.7%
ALTAR SCORE™
50th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. TAX's ALTAR Score™ is approximately 0.0 standard
deviations above the category average. This places TAX in the 50th percentile
among funds in the category.
Sell-Side Consensus
$37.76
PRICE TARGET
+28.1%
UPSIDE